Continuous Glucose Monitors
Cross-source consensus on Continuous Glucose Monitors from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Risks & contraindications
Evidence quality
Highlighted claims
- CGMs are not currently recommended as a primary diagnostic tool for insulin resistance. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- Using CGM to generate a clinical diagnosis of insulin resistance is premature given the current evidence. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- There is no validated consensus on which CGM values predict insulin resistance or diabetes transition. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- The first 14 days of CGM use may be unreliable for baseline assessment because wearing a CGM changes eating behavior. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- CGM may be useful as a behavior-change tool rather than as a diagnostic instrument. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework
- Different CGM devices placed on the same patient can produce discordant readings. — Insulin Resistance Lab Diagnostics: A Clinical Decision Framework